Sego Pharma SRL
1.7 FTESego Pharma reported total assets of 939,072 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026), with 1.7 full-time equivalent.
The score of Sego Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +21 % Headcount (avg FTE) +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sego Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 153,475 € | ||||
| Equity | 598,034 € | ||||
| Cash | 137,424 € | ||||
| EBITDA | 235,882 € | ||||
| Total assets | 939,072 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 18 Aug 2024
- Year ended 31 Dec 2022filed on 22 Aug 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
Sego Pharma's financial analysis
- Solvency63.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sego Pharma
Sego Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0825.370.030
- VAT number
- BE0825370030
- Peppol
- Registered · 0208:0825370030 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Apr 2010
- Registered office
- 2480 Dessel
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sego Pharma (SRL) has been based in Dessel since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 153,475 € and equity of 598,034 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 63.7%, above the median of its sector (44.2%).
Companies similar to Sego Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek BAKELANTS Retail sale of pharmaceutical products Geel · balance sheet €1.18m
- B.D. Farma Retail sale of pharmaceutical products Zwalm · balance sheet 562,484 €
- Instapharma Retail sale of pharmaceutical products Antwerp · balance sheet €2.12m
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Pharmacie du Parc Astrid Retail sale of pharmaceutical products Anderlecht · balance sheet 342,276 €
- DE French Retail sale of pharmaceutical products Ypres · balance sheet 981,157 €
- ETS. Vanderelst Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 898,417 €
- Gandafar Retail sale of pharmaceutical products Izegem · balance sheet 857,078 €
Frequently asked questions about Sego Pharma
What is the revenue of Sego Pharma?
Sego Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sego Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0825370030 for Sego Pharma, if the company is VAT-registered. Its company number (CBE) is 0825.370.030.
Where is the registered office of Sego Pharma?
According to the CBE register, the registered office of Sego Pharma is in 2480 Dessel.
What is the equity of Sego Pharma?
At the close of the 2025 financial year, the equity of Sego Pharma amounts to 598,034 €, a solvency of 63.7% of total assets.
How many people work at Sego Pharma?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sego Pharma?
The register lists 2 active mandates at Sego Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sego Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →